Although the New York/New Jersey (NY/NJ) area is an epicenter for carbapenem-resistant
Enterobacteriaceae (CRE), there are few multicenter studies of CRE from this region. We …

Background Patients with bacteremia due to carbapenem-resistant Enterobacterales (CRE)
experience delays until appropriate therapy and high mortality rates. Rapid molecular …

Background Open-label platform trials and a prospective meta-analysis suggest efficacy of
anti–interleukin (IL)-6R therapies in hospitalized patients with coronavirus disease 2019 (…

A randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the
ability of Echinacea purpurea to prevent infection with rhinovirus type 39 (RV-39). Forty-eight …

Salmonella bacteremia is being identified with increasing frequency in persons infected
with the human immunodeficiency virus. Salmonellosis may occur in patients with an …

▪ Objective: To determine whether naproxen, a propionic acid inhibitor of cyclooxygenase,
alters the course of experimental rhinovirus colds. ▪ Design: A randomized, double-blind, …

BACKGROUND Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody) may attenuate
the inflammatory response in Covid-19. METHODS We performed an adaptive, phase 2/3, …

Objective: To determine whether alternating regimens consisting of zidovudine and 2′,3′-dideoxycytidine
(ddC) reduce the toxicity and maintain or increase the antiretroviral effect …

Treatment of the common cold and its complications remains a continuing challenge to
physicians and other health care providers (70). Family-based studies indicate that the average …

Background Racial/ethnic minorities are at higher risk for severe COVID-19. This may be
related to social determinants that lead to chronic inflammatory states. The aims of the study …